Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer

Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3)

(2012) Prabodh K Kandala et al.   BMC Medicine

Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells

(2011) D Bose et al.   BRITISH JOURNAL OF CANCER

HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition

(2011) Karuppaiyah Selvendiran et al.   CANCER BIOLOGY & THERAPY

Ovarian cancer: Stat3, RhoA and IGF-IR as therapeutic targets

(2011) Caroline Gest et al.   CANCER LETTERS

Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells

(2011) Shuling Huang et al.   CANCER LETTERS

A Potent Oncolytic Adenovirus Selectively Blocks the STAT3 Signaling Pathway and Potentiates Cisplatin Antitumor Activity in Ovarian Cancer

(2011) Zhiqiang Han et al.   HUMAN GENE THERAPY

Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells

(2011) P Yue et al.   ONCOGENE

Necdin, a Negative Growth Regulator, Is a Novel STAT3 Target Gene Down-Regulated in Human Cancer

(2011) Rachel Haviland et al.   PLoS One

Oxygenation inhibits ovarian tumor growth by down-regulating STAT3 and cyclin-D1 expressions

(2010) Karuppaiyah Selvendiran et al.   CANCER BIOLOGY & THERAPY

Involvement of M2-polarized macrophages in the ascites from advanced epithelial ovarian carcinoma in tumor progression via Stat3 activation

(2010) Kiyomi Takaishi et al.   CANCER SCIENCE

Effects of Siltuximab on the IL-6-Induced Signaling Pathway in Ovarian Cancer

(2010) Y. Guo et al.   CLINICAL CANCER RESEARCH

The status of platinum anticancer drugs in the clinic and in clinical trials

(2010) Nial J. Wheate et al.   DALTON TRANSACTIONS

Anticancer Efficacy of a Difluorodiarylidenyl Piperidone (HO-3867) in Human Ovarian Cancer Cells and Tumor Xenografts

(2010) K. Selvendiran et al.   MOLECULAR CANCER THERAPEUTICS

Microtubule-Targeted Chemotherapeutic Agents Inhibit Signal Transducer and Activator of Transcription 3 (STAT3) Signaling

(2010) S. R. Walker et al.   MOLECULAR PHARMACOLOGY

Oct4 and LIF/Stat3 Additively Induce Krüppel Factors to Sustain Embryonic Stem Cell Self-Renewal

(2009) John Hall et al.   Cell Stem Cell

Expression of HER-2 in MCF-7 breast cancer cells modulates anti-apoptotic proteins Survivin and Bcl-2 via the extracellular signal-related kinase (ERK) and phosphoinositide-3 kinase (PI3K) signalling pathways

(2008) Aisha Siddiqa et al.   BMC CANCER

Global gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroids

(2008) Sylvain L'Espérance et al.   BMC GENOMICS

Epidermal growth factor-induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of α6β1 integrin

(2008) Michelle Colomiere et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases

(2008) Dan G. Blazer et al.   JOURNAL OF CLINICAL ONCOLOGY